I agree that this site is using cookies. You can find further informations here.
X
Abuasab, Tareq
18  results:
Search for persons X
?
1

Exploring the landscape of somatic ASXL2 mutations in myelo..:

Abuasab, Tareq ; Borthakur, Gautam ; Kanagal‐Shamanna, Rashmi...
American Journal of Hematology.  99 (2024)  7 - p. 1434-1436 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Oral decitabine and cedazuridine plus venetoclax for older ..:

Bazinet, Alexandre ; Garcia-Manero, Guillermo ; Short, Nicholas...
The Lancet Haematology.  11 (2024)  4 - p. e276-e286 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Outcomes of adult patients with relapsed/refractory CRLF2 r..:

Desikan, Sai Prasad ; Senapati, Jayastu ; Jabbour, Elias...
American Journal of Hematology.  98 (2023)  6 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

Myeloid lineage switch in KMT2A-rearranged acute lymphoblas..:

Bataller, Alex ; Abuasab, Tareq ; McCall, David...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
5

P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH ..:

Chien, Kelly ; Urrutia, Samuel ; LI, Ziyi...
HemaSphere.  7 (2023)  S3 - p. e08202e6 , 2023
Link: https://doi.org/10.1097/..
 
?
6

P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH ..:

Kelly Chien ; Samuel Urrutia ; Ziyi LI...
http://journals.lww.com/10.1097/01.HS9.0000969824.08202.e6.  , 2023
Link: https://doi.org/10.1097/..
 
?
7

P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH ..:

Chien, Kelly ; Urrutia, Samuel ; LI, Ziyi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428879/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Myeloid lineage switch in KMT2A-rearranged acute lymphoblas..:

Bataller, Alex ; Abuasab, Tareq ; McCall, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772528/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazuridine) ..:

Abuasab, Tareq ; Alvarado, Yesid ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S237 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Poster: AML-325 Prognostic Impact of RAS and C-KIT Mutation..:

Abuasab, Tareq ; Senapati, Jatastu ; Kadia, Tapan...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S133 , 2022
Link: https://doi.org/10.1016/..
 
?
11

AML-387 Clinical Characteristics of Secondary Myeloid Neopl..:

Abuasab, Tareq ; Mohamed, Shehab F. ; Biostatistics, Hyunsoo Hwang...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S243 , 2022
Link: https://doi.org/10.1016/..
 
?
12

AML-325 Prognostic Impact of and Mutations (Single vs. Mult..:

Abuasab, Tareq ; Senapati, Jatastu ; Kadia, Tapan...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S235-S236 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Poster: AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazu..:

Abuasab, Tareq ; Alvarado, Yesid ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S125 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Common kinase mutations do not impact optimal molecular res..:

Senapati, Jayastu ; Abuasab, Tareq ; Haddad, Fadi G....
American Journal of Hematology.  98 (2022)  3 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
15

Poster: AML-387 Clinical Characteristics of Secondary Myelo..:

Abuasab, Tareq ; Mohamed, Shehab F. ; Biostatistics, Hyunsoo Hwang...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S134 , 2022
Link: https://doi.org/10.1016/..
 
1-15